Skip to content
healthcare.dev

Cisatracurium besylate

NDC 68083-486, Cisatracurium besylate, injection, from Gland Pharma Limited.

Product NDC
68083-486
Status
Listed
Labeler
Gland Pharma Limited
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215516
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68083-486 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CISATRACURIUM BESYLATE2 mg/mL

Pharmacologic classes

Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
68083-486-01680830486011 VIAL, SINGLE-DOSE in 1 CARTON (68083-486-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0bacc37a-5e7f-4f05-9206-56fc8041c1ad

Use it

Look up 68083-486 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68083-486 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68083-486. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.